Protocol Ledger

NCT05889507 · Phase III · RECRUITING

Cooling in Mild Encephalopathy

Interventional Phase III clinical trial protocol NCT05889507 sponsored by Imperial College London in Rare Genetic, Women's Health, and Other, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-03-15 Enrollment: 426 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05889507
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)426 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)1 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05889507
Protocol FieldVerified Registry Value
NCT IdentifierNCT05889507
Consolidated Lead SponsorImperial College London
Therapeutic Condition CohortRare Genetic, Women's Health, and Other
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment426 participants (ESTIMATED)
Registered Start Date2024-03-15
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05889507
Hospital Research SiteLocationSite Profile
Leicester Royal InfirmaryLeicester, United KingdomOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Rare Genetic, Women's Health, and Other Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI